Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRR | Q9GZT4 | 2/20 | 0.59 |
| ▸ | ACE | P12821 | 1/20 | 0.58 |
| ▸ | PPARG | P37231 | 16/20 | 0.51 |
| ▸ | PPARA | Q07869 | 14/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28278431 | 1.00 | SRR (0.59) | SRRACEPPARGPPARA | |
| SCHEMBL8323546 | 0.87 | SLC7A5 (0.49) | SRRACEPPARGPPARA | |
| SCHEMBL8953447 | 0.85 | PPARG (0.54) | SRRACEPPARGPPARA | |
| SCHEMBL8361809 | 0.85 | SRR (0.46) | SRRACEPPARGPPARA | |
| SCHEMBL8953478 | 0.84 | PPARG (0.57) | SRRACEPPARGPPARA | |
| SCHEMBL10407749 | 0.83 | SRR (0.59) | SRRACEPPARGPPARA | |
| SCHEMBL8953769 | 0.82 | PPARA (0.58) | PPARGPPARA | |
| SCHEMBL8953590 | 0.82 | ALDH1A1 (0.42) | SRRACEPPARGPPARA | |
| SCHEMBL9554385 | 0.81 | SRR (0.57) | SRRACEPPARGPPARA | |
| SCHEMBL8953540 | 0.81 | PPARA (0.50) | ACEPPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120093737-A1 | LIGHT-ABSORBING COMPOSITIONS AND METHODS OF USE | ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS, INC. | 2012-04-19 | — | — | US | disclosed |
| US-20120076842-A1 | COSMETIC USE OF TYR-ARG DIPEPTIDE TO COMBAT CUTANEOUS SAGGING | SEDERMA (FR) | 2012-03-29 | — | — | US | disclosed |
| EP-2419076-A2 | COSMETIC COMPOSITIONS COMPRISING ORIDONIN AND NEW COSMETIC USES | Sederma (FR) | 2012-02-22 | — | — | EP | disclosed |
| US-20120028916-A1 | COSMETIC COMPOSITIONS COMPRISING ORIDONIN AND NEW COSMETIC USES | SEDERMA (FR) | 2012-02-02 | — | — | US | disclosed |
| US-20120014887-A1 | NEW COMPOUNDS, IN PARTICULAR PEPTIDES, COMPOSITIONS COMPRISING THEM AND COSMETIC AND DERMO-PHARMACEUTICAL USES | SEDERMA (FR) | 2012-01-19 | — | — | US | disclosed |
| EP-2382231-A2 | NEW COMPOUNDS, IN PARTICULAR PEPTIDES, COMPOSITIONS COMPRISING THEM AND COSMETIC AND DERMOPHARMACEUTICAL USES | Sederma (FR) | 2011-11-02 | — | — | EP | disclosed |
| EP-2382230-A2 | KXK-PEPTIDE COMPOSITIONS FOR COSMETIC AND DERMO-PHARMACEUTIC USES | Sederma (FR) | 2011-11-02 | — | — | EP | disclosed |
| US-20110250276-A1 | Cosmetic Composition Containing Acetylated Oligoglucuronans | SEDERMA, S.A.S. (FR) | 2011-10-13 | — | — | US | disclosed |
| EP-2367852-A1 | COSMETIC COMPOSITION CONTAINING ACETYLATED OLIGOGLUCURONANS | Sederma (FR) | 2011-09-28 | — | — | EP | disclosed |
| EP-2046283-B1 | COMPOSITION COMPRISING SARSASAPOGENIN | SEDERMA SA (FR) | 2011-03-16 | — | — | EP | disclosed |
| US-20110045036-A1 | Cosmetic Compositions Comprising at Least One Peptide with at Least One Immobilized Aromatic Cycle | SEDERMA (FR) | 2011-02-24 | — | — | US | disclosed |
| US-20110033507-A1 | Polypeptides KXK and Their Use | SEDERMA (FR) | 2011-02-10 | — | — | US | disclosed |
| US-20110002865-A1 | MOISTURIZING COSMETIC COMPOSITION COMPRISING A COMBINATION OF HOMARINE AND ERYTHRITOL | SEDERMA, S.A.S. (FR) | 2011-01-06 | — | — | US | disclosed |
| US-5514773-A | PARASITICIDES, ANTHELMINTICS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120014887-A1 | NEW COMPOUNDS, IN PARTICULAR PEPTIDES, COMPOSITIONS COMPRISING THEM AND COSMETIC AND DERMO-PHARMACEUTICAL USES | CUTA, PLOD3, MC1R | SRR 292/4885ACE 4562/4885PPARG 838/4885 |
| US-20110033507-A1 | Polypeptides KXK and Their Use | NPR3, NGLY1, NPR1 | SRR 1130/4885ACE 4725/4885PPARG 4217/4885 |
| US-20120076842-A1 | COSMETIC USE OF TYR-ARG DIPEPTIDE TO COMBAT CUTANEOUS SAGGING | ARGLU1, CUTA, ARG1 | SRR 905/4885ACE 3898/4885PPARG 2053/4885 |
| US-20110045036-A1 | Cosmetic Compositions Comprising at Least One Peptide with at Least One Immobilized Aromatic Cycle | TYR, XPA, MC1R | SRR 1325/4885ACE 2023/4885PPARG 2127/4885 |
| US-20110002865-A1 | MOISTURIZING COSMETIC COMPOSITION COMPRISING A COMBINATION OF HOMARINE AND ERYTHRITOL | AQP1, CUTA, AQP3 | SRR 342/4885ACE 2508/4885PPARG 4423/4885 |
| US-20110250276-A1 | Cosmetic Composition Containing Acetylated Oligoglucuronans | GLA, OGA, CUTA | SRR 4601/4885ACE 3614/4885PPARG 272/4885 |
| US-20120028916-A1 | COSMETIC COMPOSITIONS COMPRISING ORIDONIN AND NEW COSMETIC USES | DPM1, MC1R, SLTM | SRR 314/4885ACE 4657/4885PPARG 451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.